83 related articles for article (PubMed ID: 20610167)
1. Imaging of I2-imidazoline receptors by small-animal PET using 2-(3-fluoro-[4-11C]tolyl)-4,5-dihydro-1H-imidazole ([11C]FTIMD).
Kawamura K; Naganawa M; Konno F; Yui J; Wakizaka H; Yamasaki T; Yanamoto K; Hatori A; Takei M; Yoshida Y; Sakaguchi K; Fukumura T; Kimura Y; Zhang MR
Nucl Med Biol; 2010 Jul; 37(5):625-35. PubMed ID: 20610167
[TBL] [Abstract][Full Text] [Related]
2. PET study using [11C]FTIMD with ultra-high specific activity to evaluate I2-imidazoline receptors binding in rat brains.
Kawamura K; Kimura Y; Yui J; Wakizaka H; Yamasaki T; Hatori A; Kumata K; Fujinaga M; Yoshida Y; Ogawa M; Nengaki N; Fukumura T; Zhang MR
Nucl Med Biol; 2012 Feb; 39(2):199-206. PubMed ID: 21958848
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of PET probes for the imaging of I2 imidazoline receptors in peripheral tissues.
Kawamura K; Yui J; Konno F; Yamasaki T; Hatori A; Wakizaka H; Fujinaga M; Kumata K; Yoshida Y; Ogawa M; Nengaki N; Yanamoto K; Fukumura T; Zhang MR
Nucl Med Biol; 2012 Jan; 39(1):89-99. PubMed ID: 21831654
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro imaging of I₂ imidazoline receptors in the monkey brain.
Kawamura K; Maeda J; Hatori A; Okauchi T; Nagai Y; Higuchi M; Suhara T; Fukumura T; Zhang MR
Synapse; 2011 May; 65(5):452-5. PubMed ID: 21370281
[TBL] [Abstract][Full Text] [Related]
5. A useful PET probe [
Kawamura K; Shimoda Y; Yui J; Zhang Y; Yamasaki T; Wakizaka H; Hatori A; Xie L; Kumata K; Fujinaga M; Ogawa M; Kurihara Y; Nengaki N; Zhang MR
Nucl Med Biol; 2017 Feb; 45():1-7. PubMed ID: 27835825
[TBL] [Abstract][Full Text] [Related]
6. In vivo evaluation of a new ¹⁸F-labeled PET ligand, [¹⁸F]FEBU, for the imaging of I₂-imidazoline receptors.
Kawamura K; Shimoda Y; Kumata K; Fujinaga M; Yui J; Yamasaki T; Xie L; Hatori A; Wakizaka H; Kurihara Y; Ogawa M; Nengaki N; Zhang MR
Nucl Med Biol; 2015 Apr; 42(4):406-12. PubMed ID: 25583220
[TBL] [Abstract][Full Text] [Related]
7. Change in the Binding of [
Kawamura K; Yamasaki T; Zhang Y; Wakizaka H; Hatori A; Xie L; Fujinaga M; Zhang MR
Mol Imaging Biol; 2019 Feb; 21(1):105-112. PubMed ID: 29736564
[TBL] [Abstract][Full Text] [Related]
8. Imaging imidazoline-I2 binding sites in porcine brain using 11C-BU99008.
Kealey S; Turner EM; Husbands SM; Salinas CA; Jakobsen S; Tyacke RJ; Nutt DJ; Parker CA; Gee AD
J Nucl Med; 2013 Jan; 54(1):139-44. PubMed ID: 23223380
[TBL] [Abstract][Full Text] [Related]
9. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics.
Zhu Z; Guo N; Narendran R; Erritzoe D; Ekelund J; Hwang DR; Bae SA; Laruelle M; Huang Y
Nucl Med Biol; 2004 Nov; 31(8):983-94. PubMed ID: 15607480
[TBL] [Abstract][Full Text] [Related]
10. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
[TBL] [Abstract][Full Text] [Related]
11. Preclinical and the first clinical studies on [11C]CHIBA-1001 for mapping alpha7 nicotinic receptors by positron emission tomography.
Toyohara J; Sakata M; Wu J; Ishikawa M; Oda K; Ishii K; Iyo M; Hashimoto K; Ishiwata K
Ann Nucl Med; 2009 May; 23(3):301-9. PubMed ID: 19337782
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of [(11)C]methyl-losartan and [(11)C]methyl-EXP3174 for PET imaging of renal AT1receptor in rats.
Ismail B; Hadizad T; Antoun R; Lortie M; deKemp RA; Beanlands RS; DaSilva JN
Nucl Med Biol; 2015 Nov; 42(11):850-7. PubMed ID: 26300209
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline₂ binding site.
Tyacke RJ; Fisher A; Robinson ES; Grundt P; Turner EM; Husbands SM; Hudson AL; Parker CA; Nutt DJ
Synapse; 2012 Jun; 66(6):542-51. PubMed ID: 22290740
[TBL] [Abstract][Full Text] [Related]
14. Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging.
Zheng MQ; Yin DZ; Zhang L; Lei B; Cheng DF; Cai HC; Han YJ; Wu MX; Zhang H; Wang J
Acta Pharmacol Sin; 2008 May; 29(5):548-54. PubMed ID: 18430362
[TBL] [Abstract][Full Text] [Related]
15. Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's disease: an in vivo11C-BU99008 PET study.
Wilson H; Dervenoulas G; Pagano G; Tyacke RJ; Polychronis S; Myers J; Gunn RN; Rabiner EA; Nutt D; Politis M
Brain; 2019 Oct; 142(10):3116-3128. PubMed ID: 31504212
[TBL] [Abstract][Full Text] [Related]
16. 11C-AC-5216: a novel PET ligand for peripheral benzodiazepine receptors in the primate brain.
Zhang MR; Kumata K; Maeda J; Yanamoto K; Hatori A; Okada M; Higuchi M; Obayashi S; Suhara T; Suzuki K
J Nucl Med; 2007 Nov; 48(11):1853-61. PubMed ID: 17978354
[TBL] [Abstract][Full Text] [Related]
17. A PET imaging agent with fast kinetics: synthesis and in vivo evaluation of the serotonin transporter ligand [11C]2-[2-dimethylaminomethylphenylthio)]-5-fluorophenylamine ([11C]AFA).
Huang Y; Narendran R; Bae SA; Erritzoe D; Guo N; Zhu Z; Hwang DR; Laruelle M
Nucl Med Biol; 2004 Aug; 31(6):727-38. PubMed ID: 15246363
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
